Substance / Medication

Ergometrine maleate

SNOMED 126072007 UMLS C0059514

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Postpartum hemorrhage

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:

Clinical Efficacy of Calcium Gluconate Combined With Ergometrine Maleate in the Prevention of Uterine Atony-Induced Postpartum Hemorrhage and Their Effects on Coagulation Function.

Zhang Weiqiang, Shuai Wenjun, Liu Chunlan et al. · APMIS · 2025

PMID: 40159712RCT

[Multicenter, Randomized, Double-Blind, and Positive Drug-Controlled Clinical Trial on Prevention of Postpartum Hemorrhage after Vaginal Delivery with Ergometrine Maleate].

Li Tao, Wei Qiang, Wu Lin et al. · Sichuan Da Xue Xue Bao Yi Xue Ban · 2022

PMID: 35332736ObservationalFull text (PMC)

[Acute myocardial infarction produced by methylergometrine maleate-induced coronary vasospasm].

Akita Mitsuhiro, Oka Takefumi, Takamura Toshiyuki et al. · Nihon Naika Gakkai Zasshi · 2004

PMID: 15298283Case Report

[Postpartum cerebral angiopathy--a case report the vasculopathy associated with co-administration of two vasoconstrictives, methylergometrine maleate and sumatriptan].

Sato Shoichiro, Shimizu Masaru, Endo Kazuhiro et al. · Rinsho Shinkeigaku · 2004

PMID: 15199757Case Report

Effects of carbetocin combined with ergometrine maleate on blood loss and coagulation function of puerperae with postpartum haemorrhage.

Xue Hui, Wang Weijing · Am J Transl Res · 2023

PMID: 36777817OtherFull text (PMC)

Highly sensitive and selective determination of methylergometrine maleate using carbon nanofibers/silver nanoparticles composite modified carbon paste electrode.

Kalambate Pramod K, Rawool Chaitali R, Karna Shashi P et al. · Mater Sci Eng C Mater Biol Appl · 2016

PMID: 27612735Other

Inadvertent oral administration of methylergometrine maleate to children in the first months of life: from surveillance to prevention.

Davanzo Franca, Settimi Laura, Giordano Felice et al. · Pharmacoepidemiol Drug Saf · 2015

PMID: 25644278Other

A novel chemiluminescence method for the determination of ergometrine maleate in serum sample without chemiluminescence reagent.

Hu Yufei, Zhang Zhujun, Li Gongke · Talanta · 2010

PMID: 20188953Other

Methyl-ergometrine maleate from synchrotron powder diffraction data.

Rohlíček Jan, Hušák Michal, Kratochvíl Bohumil et al. · Acta Crystallogr Sect E Struct Rep Online · 2009

PMID: 21578950OtherFull text (PMC)

Effect of estradiol 17beta upon coronary artery vasoconstrictor response to methylergometrine maleate in female menopausal patients.

Rosano Giuseppe M C, Collins Peter, Gerbara Otavio et al. · Int J Cardiol · 2006

PMID: 16412806Other

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type: Substance / Medication
Fully Specified Name: Ergometrine maleate (substance)
SNOMED CT: 126072007
UMLS CUI: C0059514

Clinical Data

This intervention maps to 1 entities in the Healos knowledge graph.

Conditions

Biomarkers

Specialists

Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.